Reduced Numbers of Corticotropin-Releasing Hormone Neurons in Narcolepsy Type 1.
Journal Information
Full Title: Ann Neurol
Abbreviation: Ann Neurol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential Conflicts of Interest L.S., R.F., and G.J.L. have received research support from Jazz Pharma (Solriamfetol is a Jazz Pharma medication used in the treatment of excessive sleepiness) and Bioprojet (Pitolisant, manufactured by Bioprojet, is used in the treatment of narcolepsy). R.F. and G.J.L. have received consultancy fees from Bioprojet."
"L.S. has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska‐Curie grant (Agreement No. 707404) and has been awarded the Young Scientist Award 2020 by the European Narcolepsy Network (supported by the Klaus‐Grawe Foundation). D.F.S. and L.S. were supported by Friends of the Netherlands Institute for Neuroscience Foundation. This work was partially supported by research grants from the Bioprojet‐Biotech, Saint Gregoire, France. The funding agencies had no role in the design of the study, nor in the collection, analysis, or interpretation of data."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025